T. Koide

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
T Koide, T. Koide, Tohru Koide
Publication record
44 papers · 1,832 citations · H-index 18

PAPERS

Protective effect of FR115427 against ischemic hippocampal damage in gerbils.
199413 citationsauthor #3
Effects of protein kinase C activators on Na, K-ATPase activity in rat brain microvessels.
19940 citationsauthor #4
A narrow therapeutical window of a nitric oxide synthase inhibitor against transient ischemic brain injury.
199327 citationsauthor #4
Functional roles of cyclic guanosine 3',5'-monophosphate analogue in cerebral vasodilation.
19932 citationsauthor #3
Effects of protein kinase C agonists on Na,K-ATPase activity in rat brain microvessels.
19933 citationsauthor #4
Blockade of nitric oxide formation by Nω-nitro-l-arginine mitigates ischemic brain edema and subsequent cerebral infarction in rats
1992137 citationsauthor #3
Neurochemical correlates of selective neuronal loss following cerebral ischemia: role of decreased Na+,K(+)-ATPase activity.
199239 citationsauthor #2
BY-1949 elicits vasodilation via preferential elevation of cyclic GMP levels within the cerebral artery: possible involvement of endothelium-mediated mechanisms.
19928 citationsauthor #2
An Activation of Synaptosomal Na+, K+‐ATPase by a Novel Dibenzoxazepine Derivative (BY‐1949) in the Rat Brain: Its Functional Role in the Neurotransmitter Uptake Systems
19926 citationsauthor #2
Phorbol 12,13-Diacetate-Induced Contraction of the Canine Basilar Artery: Role of Protein Kinase C
199151 citationsauthor #2
The role of cGMP in the anti-aggregating properties of BY-1949, a novel dibenzoxazepine derivative.
199113 citationsauthor #3
A novel dibenzoxazepine derivative (BY-1949) increases regional cerebral blood flow.
19904 citationsauthor #2
Pyruvate Dehydrogenase Activity in the Rat Cerebral Cortex following Cerebral Ischemia
198960 citationsauthor #2
The role of free radicals and eicosanoids in the pathogenetic mechanism underlying ischemic brain edema.
198941 citationsauthor #2
Neurochemical analysis of delayed neuronal death following cerebral ischemia in rats
19880 citationsauthor #2
To the Editor
19870 citationsauthor #1
Role of peroxides in the cerebral transmembrane ion fluxes and their relevance to ischemic brain edema
19870 citationsauthor #1
Chronic Dexamethasone Pretreatment Aggravates Ischemic Neuronal Necrosis
1986175 citationsauthor #1
Enhancement of ATPase Activity by a Lipid Peroxide of Arachidonic Acid in Rat Brain Microvessels
198652 citationsauthor #1
Circulating Catecholamines Modulate Ischemic Brain Damage
1986113 citationsauthor #1
Role of the arachidonate cascade in the pathogenetic mechanism of cerebral vasospasm following subarachnoid hemorrhage.
19852 citationsauthor #3
Alterations of the Eicosanoid Synthetic Capacity of Rat Brain Microvessels Following Ischemia: Relevance to Ischemic Brain Edema
198570 citationsauthor #1
Enhancement of the Na, K-ATPase Activity of the Brain Microvessel by Arachidonic Acid and Its Hydroperoxide, 15-HPAA
19850 citationsauthor #2
Influence of Acidosis on Lipid Peroxidation in Brain Tissues in vitro
1985278 citationsauthor #3
[The pathomechanism underlying ischemic brain edema: the role of Na+, K+-ATPase of the brain microvessels].
19854 citationsauthor #5
Ischemic brain edema following occlusion of the middle cerebral artery in the rat. II: Alteration of the eicosanoid synthesis profile of brain microvessels.
198583 citationsauthor #3
Ischemic brain edema following occlusion of the middle cerebral artery in the rat. I: The time courses of the brain water, sodium and potassium contents and blood-brain barrier permeability to 125I-albumin.
1985328 citationsauthor #3
Experimental evaluation of the beneficial effect of an antioxidant on cerebral vasospasm.
198465 citationsauthor #3
Effects of AVS (1,2-bis(nicotinamido)propane) on platelet function and vascular endothelium.
19846 citationsauthor #4
A Model to Study Ischemic Brain Edema in Rats and the Influence of Drugs
198412 citationsauthor #2
Amelioration of ischaemic cerebral oedema by a free radical scavenger, AVS: 1,2-bis(nicotinamido)-propane. An experimental study using a regional ischaemia model in cats.
198449 citationsauthor #3
Prevention of the ischemic brain edema by a radical scavenger(AVS)
19831 citationsauthor #1
Improving effect of BY-1947 on learning-memory deficiency [I]: its screening and pharmacological profile
19830 citationsauthor #4
LIPIDPEROXIDATION AND CEREBRAL VASOSPASM : A BENEFICIAL PHARMACOLOGICAL APPROACH BY AVS (A RADICAL SCAVENGER)
19835 citationsauthor #1
Possible mechanisms of 15-hydroperoxyarachidonic acid-induced contraction of the canine basilar artery in vitro.
198254 citationsauthor #1
Influence of a chronic new potential antidepressant, 1-[3-(dimethylamino)propyl]-5-methyl-3-phenyl-1H-indazole(FS32) and its N-desmethylated compound(FS97): treatment on monoaminergic receptor sensitivity in the rat brain.
198116 citationsauthor #1
An enhanced sensitivity of muscarinic cholinergic receptor associated with dopaminergic receptor subsensitivity after chronic antidepressant treatment.
198132 citationsauthor #1
Contraction of the Canine Basilar Artery following Linoleic, Arachidonic, 13-Hydroperoxylinoleic, or 15-Hydroperoxyarachidonic Acid
198135 citationsauthor #1
Preferential inhibition of type B-MAO by new compounds, 1-[3-(dimethylamino)propyl]-5-methyl-3-phenyl-1h-indazole(Fs32) and its N-desmethylated derivative (FS97).
19806 citationsauthor #1
Neuropharmacological Properties of New Non-tricyclic Compounds(FS32, FS97).
19800 citationsauthor #1
Inhibition of (3H)-dopamine uptake into rat brain synaptosomes by the new non-tricyclic antidepressants, FS32 and FS97.
198011 citationsauthor #1
A comparison of the inhibitory effects of new non-tricyclic amine uptake inhibitors on the uptake of norepinephrine and 5-hydroxytryptamine into synaptosomes of the rat brain.
198015 citationsauthor #1
Pharmacological studies on a new thymoleptic antidepressant, 1-[3-(dimethylamino)propyl]-5-methyl-3-phenyl-1H-indazole (FS-32).
197916 citationsauthor #5
Pharmacodynamic actions of (S)-2-[4,5-dihydro-5-propyl-2-(3H)-furylidene]-1,3-cyclopentanedione (oudenone).
19760 citationsauthor #2

TIMELINE

1976 0 citations

1979 16 citations

1980 32 citations

1981 83 citations

1982 54 citations

1983 6 citations

1984 132 citations

1985 765 citations

1986 340 citations

1987 0 citations

1988 0 citations

1989 101 citations

1990 4 citations

1991 64 citations

1992 190 citations

1993 32 citations

1994 13 citations

T. Koide

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT